SynthesisCurrent oncology reports2026
Feasibility of High-Intensity Interval Training Before, During, and After Cancer Treatment: A Systematic Review and Meta-Analysis.
Synthesis in Current oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo systematically evaluate the feasibility and safety of high-intensity interval training (HIIT) interventions in cancer populations across the cancer care continuum (before, during, and after cancer treatment).
methodsThis systematic review and meta-analysis followed PRISMA guidelines and was registered in PROSPERO. PubMed, Scopus, and Web of Science were searched from inception to 31 December 2025. Studies were included if they enrolled adults with cancer, implemented a HIIT intervention, and reported feasibility outcomes. Recruitment, adherence, and dropout outcomes were calculated as study-specific proportions with 95% confidence intervals and pooled using random-effects models with REML estimation. Risk of bias was assessed using RoB 2 for RCTs and MMAT for non-randomized studies, while certainty of evidence was evaluated using GRADE.
resultsTwenty-two studies were included, comprising 559 participants in HIIT groups. Pooled recruitment across 20 studies was 0.57 (95% CI: 0.41-0.72), pooled adherence across 21 studies was 0.91 (95% CI: 0.86-0.95), and pooled dropout across 20 studies was 0.11 (95% CI: 0.06-0.16). Recruitment showed considerable heterogeneity, whereas adherence and dropout showed moderate heterogeneity. No statistically significant subgroup differences were observed by study design, intervention setting, treatment phase, or exercise frequency. Adverse events were reported in six studies, with no serious adverse events.
conclusionsHIIT appears feasible and safe for individuals with cancer, particularly after enrolment. However, recruitment remains moderate, and findings should be interpreted cautiously due to heterogeneity, risk of bias, and limited certainty of evidence.
Indexed as
Identifiers
43018843What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.